Fact Sheet for Healthcare Providers: NeoPlex ™ COVID-19 Detection Kit – GeneMatrix, Inc.

Source: U.S. Food and Drug Administration (FDA). Published: 5/14/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the NeoPlex ™ COVID-19 Detection Kit, which received an Emergency Use Authorization from the Food and Drug Administration on May 14, 2020. The NeoPlex™ COVID-19 Detection Kit is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)

https://disasterinfo.nlm.nih.gov/search/id:22224

Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 14, 2020 Category: International Medicine & Public Health Source Type: news

More News: COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | International Medicine & Public Health | Respiratory Medicine